Pump and dump stocks ... Mineralys Therapeutics, Inc. (NASDAQ:MLYS) released topline data from its pivotal Launch-HTN Phase 3 and pivotal Advance-HTN Phase 2 trials of lorundrostat for ...

BorgWarner will showcase its latest commercial vehicle (CV) solutions at the Advanced Clean Transportation (ACT) Expo 2025. The company will highlight its comprehensive portfolio of highly efficient ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

Amsino has taken a significant step forward in our mission to advance healthcare worldwide. We are proud to announce the establishment of Amsino Scientific Inc., a new medical device manufacturing, ...

A University of Minnesota research team earned a $11.6 million grant to work with the Mayo Clinic on a device designed to ...

Ligand and Channel Therapeutics announce a merger to advance ZELSUVMI™, a new treatment for molluscum contagiosum, supported by $50 million in funding. Ligand Pharmaceuticals and Channel ...

To advance this partnership, Ona Therapeutics—working in collaboration with the U.S. subsidiary of REVEAL GENOMICS—has been awarded a grant from CDTI (Centro para el Desarrollo Tecnológico y ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

This partnership aims to design, engineer, and develop antibodies with enhanced functionality and improved biophysical properties to create therapeutics ... has built and advanced a pipeline ...

Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...